NCT04929015View on ClinicalTrials.gov

Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 29, 2021

Primary Completion Date

November 1, 2024

Study Completion Date

November 1, 2024

Conditions
Appendix Carcinoma by AJCC V8 StageColorectal Carcinoma by AJCC V8 StageDigestive System NeoplasmEsophageal Carcinoma by AJCC V8 StageGastric Carcinoma by AJCC V8 StageLiver and Intrahepatic Bile Duct CarcinomaPeritoneal Carcinomatosis
Interventions
PROCEDURE

Biospecimen Collection - blood and tissue sample collection

The original tissue sample from each patient will be obtained at time of surgery or prior to surgery. Plasma for ctDNA will be obtained at baseline, pre-surgery, post-surgery and every 3 months up 2 years

OTHER

Electronic Health Record Review

Medical record reviewed

Trial Locations (2)

07039

RECRUITING

RWJBarnabas Health - Cooperman Barnabas, Livingston, Livingston

08903

RECRUITING

Rutgers Cancer Institute of New Jersey, New Brunswick

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Rutgers, The State University of New Jersey

OTHER